NVIDIA Corporation is a leading technology company primarily known for its innovations in graphics processing units (GPUs) that enhance visual computing across various applications, including gaming, professional visualization, and artificial intelligence. Beyond its strong presence in gaming, NVIDIA's products are integral to deep learning and data center solutions, empowering advancements in machine learning, autonomous vehicles, and high-performance computing. By leveraging its cutting-edge technologies, NVIDIA aims to drive the future of computing and improve experiences across industries, from entertainment to scientific research. Read More
Zuckerberg warns US must match China's AI investments in data centers and hardware to stay competitive. The Meta Platforms CEO believes the US' chip export controls are significantly reshaping the wider AI race.
The Trump administration is reportedly considering replacing Biden-era AI chip export tiers with a stricter global licensing system, potentially tightening access to Nvidia's H100 chips and reshaping U.S. tech trade policy.
Notwithstanding the resurgence seen since last week, the market is likely to end April with a monthly loss, with the S&P 500 down 0.90% with a session to go.
The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top S&P500 gainers and losers driving the post-market movements.
Online travel agency Booking Holdings (NASDAQ:BKNG) announced better-than-expected revenue in Q1 CY2025, with sales up 7.9% year on year to $4.76 billion. Its non-GAAP profit of $24.81 per share was 41.2% above analysts’ consensus estimates.
Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Tuesday and discover the stocks that are dominating the trading activity and setting the pace for the market.
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 34.9% in the pre-market session after Novo Nordisk announced plans to offer its weight loss drug Wegovy through the company's (Hims & Hers Health's) platform, expanding access to one of its fastest-growing products. By partnering with a popular telehealth company, Novo could speed up Wegovy's adoption, leading to more prescriptions. For investors, the deal signals a clear strategy to expand distribution and grab more market share, a move that could also boost sales growth for Hims & Hers (HIMS).
Intel plans to build test chips for new manufacturing process, aims to win market share from TSM. CEO Lip-Bu Tan to share progress and partnerships at foundry event.
As President Donald Trump marks 100 days in office, four tech giants who backed his second term have seen their fortunes and their companies' stock values take a hit.
